Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | EVP, Chief of Strategic Dev. | February 19, 2020 | February 21, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date February 19, 2020 · Filed February 21, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,128,560 |
Last balance in matching sequence
After 2020-02-19 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2020-02-19 · Exercise / conversion · Acquired 447,472 · Balance 1,085,513 F1: This amount eliminates two shares which, as a result of a mathematical error, were first inadvertently included in the amount of securities beneficially owned beginning with the Reporting Person's Form 4 filed October 24, 2019. Row 2 · 2020-02-19 · Exercise / conversion · Acquired 43,047 · Balance 1,128,560 F1: This amount eliminates two shares which, as a result of a mathematical error, were first inadvertently included in the amount of securities beneficially owned beginning with the Reporting Person's Form 4 filed October 24, 2019. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.87 · Expires 2025-09-15 | Direct | 174,914 |
Reported balance
After 2020-02-19 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-02-19 · Exercise / conversion · Disposed 447,472 · Balance 174,914 F2: Fully Vested. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.91 · Expires 2027-08-03 | Direct | 344,377 |
Reported balance
After 2020-02-19 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-02-19 · Exercise / conversion · Disposed 43,047 · Balance 344,377 F3: One-fourth (1/4th) of the shares subject to the Option vested on April 1, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. |
Filing footnotes · ownership attribution and instrument terms
F1: This amount eliminates two shares which, as a result of a mathematical error, were first inadvertently included in the amount of securities beneficially owned beginning with the Reporting Person's Form 4 filed October 24, 2019.
F2: Fully Vested.
F3: One-fourth (1/4th) of the shares subject to the Option vested on April 1, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 19, 2020 Filed Feb 21, 2020 21:38 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 43,047 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001209191-20-011559 · doc4.xml · derivative · entry 4 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 344,377 Underlying: Common Stock · 43,047 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on April 1, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:38 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 447,472 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001209191-20-011559 · doc4.xml · derivative · entry 3 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 174,914 Underlying: Common Stock · 447,472 shares Expires 2025-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully Vested. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:38 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 43,047 | $0.91 | $39,172.77 |
DisclosureSEC source: 0001209191-20-011559 · doc4.xml · nonDerivative · entry 2 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,128,560 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This amount eliminates two shares which, as a result of a mathematical error, were first inadvertently included in the amount of securities beneficially owned beginning with the Reporting Person's Form 4 filed October 24, 2019. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 21:38 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 447,472 | $0.87 | $389,300.64 |
DisclosureSEC source: 0001209191-20-011559 · doc4.xml · nonDerivative · entry 1 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,085,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: This amount eliminates two shares which, as a result of a mathematical error, were first inadvertently included in the amount of securities beneficially owned beginning with the Reporting Person's Form 4 filed October 24, 2019. Read SEC document |
| October 29, 2019 Filed Oct 30, 2019 01:15 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 384,003 | $12.22 | $4,692,516.66 |
DisclosureSEC source: 0001209191-19-054416 · doc4.xml · nonDerivative · entry 1 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 638,043 F1 · price: These shares were sold by the Reporting Person as a selling stockholder pursuant to an underwritten public offering by the Issuer. The reported sale price reflects the price at which the Reporting Person sold shares to the underwriters. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 01:55 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 199,986 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001209191-19-054027 · doc4.xml · derivative · entry 4 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 387,424 Underlying: Common Stock · 199,986 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the Option vested on April 1, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 01:55 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 64,017 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001209191-19-054027 · doc4.xml · derivative · entry 3 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622,386 Underlying: Common Stock · 64,017 shares Expires 2025-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Fully Vested. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 01:55 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 199,986 | $0.91 | $181,987.26 |
DisclosureSEC source: 0001209191-19-054027 · doc4.xml · nonDerivative · entry 2 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,022,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2019 Filed Oct 25, 2019 01:55 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 64,017 | $0.87 | $55,694.79 |
DisclosureSEC source: 0001209191-19-054027 · doc4.xml · nonDerivative · entry 1 Ajmani Karin · CIK 0001789516 · EVP, Chief of Strategic Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 822,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.